๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› South Korea
Clinical trial register · South Korea

Studies with a South Korean investigative site

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3364 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:49 UTC
3364
Studies in scope
all four open statuses
1829
Recruiting now
open to new participants
503
Lead sponsors
across recruiting studies
Top sites
Seoul 2820 Daegu 550 Seongnam-si 485 Busan 464 Goyang-si 395
Narrow the register
Recruitment status
Phase
Lead sponsor
Seoul National University Hospital203 AstraZeneca201 Yonsei University174 Samsung Medical Center148 Merck Sharp & Dohme LLC118
Site location
Seoul2820 Daegu550 Seongnam-si485 Busan464 Goyang-si395
All 252 locations
Target enrolment
to

Trials in this register

3364 of 3364 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS
NCT07146178Gynecologic Surgery, General Anesthesia
Wonju Severance Christian Hospital
Not applicable
200
Wลnju
2025-09-01
Not yet open
Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery
NCT06144112Liver Diseases
DrugsFresh frozen plasma·Prothrombin Complex
Konkuk University Medical Center
Phase 4
92
Seoul
2025-09-01
Recruiting
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
NCT07142226Biliary Tract Cancer
CHA University
Observational
200
Seongnam-si
2025-09-01
Recruiting
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT07144176Healthy Subjects
Daewoong Pharmaceutical Co. LTD.
Phase 1
60
Seoul
2025-09
Not yet open
Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure
NCT07123506Atrial Fibrillation, Atrial Flutter, Tachycardia, Supraventricular, Heart Septal Defects, Atrial
Yonsei University
Not applicable
350
Seoul
2025-09
Not yet open
Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors
NCT07108985Diabetes Mellitus, Type 2, Hyperglycemia, Insulin Resistance
DrugsSitagliptin·Dapagliflozin
Yonsei University
Phase 4
100
Seoul
2025-09
Not yet open
The Effects of Stroboscopic Visual Conditions on Gait and Lower Limb Muscle Activity in Individuals With Chronic Ankle Instability
NCT07134829Chronic Ankle Instability
Sahmyook University
Not applicable
25
Seoul
2025-08-31
Recruiting
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269Biliary Dyspepsia
Myungmoon Pharma. Co. Ltd.
Phase 4
358
Ansan, Suwon, Busan, Gyeonggi-do, Incheon, Seoul
2025-08-29
Recruiting
COPM-Based Goal Setting Strategies in the PICU
NCT07128446Critical Illness, Pediatric Intensive Care Unit
Samsung Medical Center
Not applicable
5
Seoul
2025-08-29
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
NCT07128303Advanced Solid Tumor
DrugsPemetrexed·Carboplatin·Pembrolizumab
Gilead Sciences
Phase 1
476
Seoul
2025-08-28
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Wลnju, Gyeonggi-do, Seoul, Cheonan, Daegu
2025-08-28
Recruiting
Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults
NCT07161180Healthy Volunteers
Pharmbio Korea Co., Ltd.
Phase 1
32
Seoul
2025-08-27
Recruiting
mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
NCT07062536Biliary Cancer Metastatic
DrugMFOLFOX
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
Recruiting
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
NCT07152119Severe Alopecia Areata
DrugLitfulo
Pfizer
Observational
3,000
Seoul
2025-08-27
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07043400Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Drugs5-FU·Leucovorin·Adrucil·Tislelizumab
BeOne Medicines
Phase 3
351
Seongnam-si, BukGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-08-27
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
DrugsCapivasertib·Fulvestrant
Relay Therapeutics, Inc.
Phase 3
540
Seongnam-si, Seoul
2025-08-26
Recruiting
A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)
NCT07164833Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury
Bilix Co.,Ltd.
Phase 2
50
Daegu, Seongnam, Seoul, Yangsan
2025-08-26
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
NCT07160244Healthy
Drug20-valent pneumococcal conjugate vaccine
Pfizer
Phase 3
6,000
Chuncheon, Gwangju, Seoul, Daegu
2025-08-25
Recruiting
An International Observational Study of Adults With Acute Infection
NCT07069400Infectious Disease
University of Minnesota
Observational
1,500
Seongnam-si, Seoul
2025-08-25
Not yet open
Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer
NCT07125924Bladder Cancer, Radiation Cystitis
National Cancer Center, Korea
Not applicable
54
Goyang-si
2025-08-22
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Busan, Seoul
2025-08-22
Recruiting
Effectiveness and Safety of Pharmacopuncture Therapy for Chronic Lumbar Radiculopathy: A Multicenter, Pragmatic, Randomized, Comparative Clinical Trial
NCT07832318Lumbar Radiculopathy, Chronic Pain
Jaseng Medical Foundation
Not applicable
92
Bucheon-si, Seongnam-si, Seoul
2025-08-22
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Seoul
2025-08-21
Active, closed
Real-world Immunogenicity of Anti-IL5/5a Antibody
NCT07567690Asthma, Immunogenicity, Biologics
Samsung Medical Center
Observational
100
Seoul
2025-08-19
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsASP5541·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Daegu, Gwangju, Seoul
2025-08-19
Recruiting
A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients
NCT06845553Knee Osteoarthritis (Knee OA)
Glaceum
Phase 2
60
Seongnam-si
2025-08-19
Recruiting
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT06954714Coronary Artery Disease
Chonnam National University Hospital
Not applicable
256
Busan, Daegu, Gwangju, Jeonju, Seoul, Ulsan
2025-08-18
Active, closed
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
NCT07005128Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
DrugsTarlatamab·Etoposide·Durvalumab·Carboplatin
Amgen
Phase 3
350
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Seoul
2025-08-18
Recruiting
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
NCT07196501Major Depressive Disorder
DrugNBI-1065845
Neurocrine Biosciences
Phase 3
550
Ansan-si, Seoul
2025-08-18
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192Psychosis Associated With Alzheimer's Disease
DrugML-007C-MA
MapLight Therapeutics
Phase 2
300
Daegu, Incheon
2025-08-15
Not yet open
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
NCT06942156Heart Transplant
DrugsMycophenolate Mofetil·Everolimus
Chong Kun Dang Pharmaceutical
Phase 4
140
Seoul
2025-08-14
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318Immune Thrombocytopenic Purpura (ITP)
DrugMezagitamab
Takeda
Phase 3
150
Seongnam-si, Daegu, Seoul
2025-08-14
Recruiting
Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709Alzheimer's Disease
GlaxoSmithKline
Phase 2
220
Junggu
2025-08-14
Recruiting
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
NCT06770543Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
1,500
Yangsan, Busan, Seoul, Taegu
2025-08-13
Recruiting
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
NCT07073677Mild to Moderate Atopic Dermatitis
HK inno.N Corporation
Phase 2
162
Ansan
2025-08-12
By invitation
NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd
NCT07132749Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd, Patients With HER2-low Advanced Breast Cancer Treated With T-DXd
Yeon Hee Park
Observational
100
Seoul
2025-08-12
Recruiting
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
NCT07162441Dyslipidemia
Korea United Pharm. Inc.
Phase 1
50
Seoul
2025-08-12
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
NCT07099898Neoplasms, Lung
DrugsRis-Rez·Topotecan
GlaxoSmithKline
Phase 3
420
Changwon, Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Seongnam-si Gyeonggi-do, Seoul, Suwon Gyeonggi-do, Ulsan
2025-08-11
Active, closed
Evaluate the Efficacy and Safety of CTO0308 in Pediatric Patients With Myopia
NCT07790640Myopia
Taejoon Pharmaceutical Co., Ltd.
Phase 3
351
Incheon
2025-08-11
Recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
NCT07094516Alzheimer's Disease
DrugVHB937
Novartis Pharmaceuticals
Phase 2
407
Seoul, Incheon
2025-08-07
Recruiting
Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients
NCT07609186Cataract, Binaural Beats, Geriatric Anesthesia
Seoul National University Hospital
Not applicable
60
Seoul
2025-08-07
Recruiting
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
NCT07098338Non-Small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Datopotamab Deruxtecan
AstraZeneca
Phase 2
278
Cheongju-si, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-08-07
Active, closed
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
NCT07092865Respiratory Syncytial Virus Infections
GlaxoSmithKline
Phase 2
168
Seoul
2025-08-06
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
NCT07027072Mild Cognitive Impairment (MCI), Mild Dementia, Alzheimer's Disease
DrugKDS2010
NeuroBiogen Co., Ltd
Phase 2
114
Gwangju, Guri-si, Suwon, Incheon, Seoul
2025-08-06
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT06952803Prostate Cancer
DrugsPrednisolone/Prednisone·Saruparib·Abiraterone
AstraZeneca
Phase 3
700
Busan, Daegu, Goyang-si, Seongnam-si, Seoul
2025-08-06
Recruiting
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
NCT07158918Solid Tumors
DrugsABL103·Keytruda·Pembrolizumab
ABL Bio, Inc.
Phase 1/2
65
Seongnam, Seoul
2025-08-06
Recruiting
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
NCT06982573End-Stage Renal Disease
Bundang CHA Hospital
Not applicable
18
Seongnam-si
2025-08-06
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965Breast Cancer
DrugsPF-07248144·Exemestane·Everolimus·Fulvestrant
Pfizer
Phase 3
400
Seongnam-si, Gangnam-gu, Seoul
2025-08-05
Recruiting
RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy
NCT06930092Ischemic Cardiomyopathy
Seoul National University Hospital
Not applicable
158
Seoul
2025-08-03
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
NCT07005102Non-Squamous Non-Small Cell Lung Cancer
DrugsTelisotuzumab Adizutecan·Osimertinib·Pemetrexed·Cisplatin
AbbVie
Phase 2/3
854
Busan, Cheongju-si, Seoul
2025-08-03
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
NCT07044336Endometrial Cancer, Malignant Solid Tumour
DrugsAdriamycin·Taxol·Doxorubicin·Paclitaxel
AstraZeneca
Phase 3
800
Goyang-si, Gwangjin-gu, Seoul, Songpa-gu, Suwon
2025-08-01
Active, closed
Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms
NCT07484412Lower Abdominal Pain, Diarrhea, Irritable Bowel Syndrome
Seoul National University Bundang Hospital
Not applicable
88
Seongnam-si
2025-08-01
Recruiting
Prospective CT Assessment After DCB
NCT07373145Coronary Artery Disease
Seoul National University Hospital
Observational
165
Seoul
2025-08-01
Not yet open
Thickness Map-Guided vs. Empirical PV Isolation Using Pulsed Field Ablation for Paroxysmal AF
NCT07068646Atrial Fibrillation
Yonsei University
Not applicable
298
Seoul
2025-08
Not yet open
A Study to Evaluate Safety and Efficacy of PBK_M2502
NCT07114406Intestinal Disease, Colonic Diseases, Gastrointestinal Disease, Digestive System Disease
Pharmbio Korea Co., Ltd.
Phase 3
110
Seoul
2025-08
Not yet open
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults
NCT07034781Type2 Diabetes Mellitus
AJU Pharm Co., Ltd.
Phase 1
50
Gwangmyeong
2025-08
Not yet open
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
NCT07068633Heart Valve Diseases, Aortic Valve Stenosis, Aortic Valve Insufficiency, Mitral Valve Insufficiency
Yonsei University
Observational
30,000
Seoul
2025-08
Recruiting
EOI Block for Laparoscopic Gastrostomy
NCT07119346Gastrostomy
Seoul National University Hospital
Not applicable
40
Seoul
2025-08
Not yet open
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study
NCT07044765Type2 Diabetes Mellitus
AJU Pharm Co., Ltd.
Phase 1
32
Gwangmyeong
2025-08
Active, closed
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
NCT07709637COVID-19, COVID-19 (SARS-CoV-2 Infection)
LucasBio
Phase 1
1
Seoul
2025-07-31
Recruiting
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT07094113KRAS Altered Advanced or Metastatic Solid Tumors
DrugsPanitumumab·Pembrolizumab
Amgen
Phase 1
434
Seoul
2025-07-31
Recruiting
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
NCT07096193Chronic Hepatitis Delta
Gilead Sciences
Phase 1/2
200
Ansan-si, Bucheon-si, Seoul
2025-07-31
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013Immune Thrombocytopenia (ITP)
DrugPirtobrutinib
Eli Lilly and Company
Phase 1/2
68
Busan, Seoul
2025-07-30
Recruiting
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
NCT06922890Spinal Cord Injury, Chronic Spinal Cord Injury
Yonsei University
Phase 1/2
9
Seoul
2025-07-30
Recruiting
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
NCT06780111Esophageal Squamous Cell Carcinoma
DrugsLevoleucovorin·Ifinatamab Deruxtecan·Sacituzumab tirumotecan·5-FU
Merck Sharp & Dohme LLC
Phase 1/2
298
Goyang-si, Seoul
2025-07-30
Recruiting
Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study
NCT07395752Suicidal Ideation, Self-Injurious Behavior, Suicide, Attempted
Ajou University School of Medicine
Not applicable
100
Suwon
2025-07-30
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
NCT07009171Overweight, Obesity, Obese Patients
DrugKDS2010
NeuroBiogen Co., Ltd
Phase 2
75
Suwon, Seoul
2025-07-29
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma
DrugRilvegostomig
AstraZeneca
Phase 1/2
120
Seoul
2025-07-29
Recruiting
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
NCT07083206Hypercholesterolemia, Dyslipidemias
Ahn-Gook Pharmaceuticals Co.,Ltd
Observational
4,500
Yongin-si
2025-07-29
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
DrugsCisplatin·Carboplatin·Pembrolizumab
Eli Lilly and Company
Phase 1
240
Seoul
2025-07-28
Recruiting
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
NCT07005752Cholesterol Cholelithiasis
Myungmoon Pharma. Co. Ltd.
Phase 4
484
Ansan, Bucheon-si, Suwon, Busan, Daegu, Gyeonggi-do, Incheon, Seoul
2025-07-28
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
220
Cheonan, Guri-si, Seongnam-si, Seoul
2025-07-28
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519Ulcerative Colitis
DrugRisankizumab
AbbVie
Phase 3
120
Yangsan, Seoul
2025-07-28
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
NCT06911502Follicular Lymphoma
DrugsPrednisone/Prednisolone·Golcadomide·Bendamustine·Vincristine
Celgene
Phase 3
400
Seoul
2025-07-28
Active, closed
A Study to Investigate the Efficacy and Safety of Volrustomig ยฑ Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
NCT07000149Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Volrustomig
AstraZeneca
Phase 1
9
Busan, Seoul
2025-07-28
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Gyeonggi-do, Seoul, Ulsan, Wonju-si, Gangwon-do
2025-07-25
Recruiting
FDG PET-CT in Advanced Breast Cancer
NCT07173868Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment Available, If There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center
Observational
100
Seoul
2025-07-25
Recruiting
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
NCT06676280Cardiovascular Diseases
DrugsHigh-intensity statin·Aspirin
Jung-min Ahn
Phase 4
5,000
Anyang, Bucheon-si, Busan, Changwon, Cheonju, Chuncheon, Daegu, Daejeon
2025-07-24
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634Breast Cancer
DrugsGedatolisib·Ribociclib·Palbociclib·Letrozole
Celcuity Inc
Phase 3
1,180
Goyang, Incheon, Seongnam-si, Seoul, Suwon, Ulsan
2025-07-24
By invitation
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
NCT06743243General Anesthesia
DrugsFamotidine·Tegoprazan
Seok Kyeong Oh
Phase 4
174
Seoul
2025-07-23
Recruiting
Fluorescence Lymph Node Mapping for Colon Cancer Surgery
NCT07060443Right Hemicolectomy
Pusan National University Yangsan Hospital
Phase 2
186
Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2025-07-23
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsSigvotatug vedotin·Pembrolizumab
Pfizer
Phase 3
714
Hwasun-gun, Seongnam, Suwon, Busan, Haeundae-gu, Seoul, Deagu
2025-07-23
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,800
Ansan-si, Bucheon-si, Busan, Daejeon, Daejoen, Gwangju, Incheon, Seongnam
2025-07-22
Active, closed
Multiomics Profiling of CSF in Cardiac Arrest Survivors
NCT07090577Cardiac Arrest (CA), Hypoxic-Ischemic Brain Injury, Post-Resuscitation Syndrome
Chungnam National University Hospital
Observational
15
Daejeon
2025-07-22
Recruiting
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
NCT06550882Acquired Hemophilia A
DrugsSusoctocog Alfa·Vaxzevria
Takeda
Observational
9
Seoul, Ulsan
2025-07-22
Recruiting
Application-Based Integrated Care in Patients After Pulse Field Ablation
NCT07119528Atrial Fibrillation Patients Treated With the FARAPULSEโ„ข PFA System
Yonsei University
Not applicable
500
Seoul
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Seoul
2025-07-21
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807Breast Neoplasms
DrugsLiposomal doxorubicin·Patritumab deruxtecan·Xeloda·Abraxane
Merck Sharp & Dohme LLC
Phase 3
1,000
Seongnam, Gangnam-gu, Jongno-Gu, Seoul
2025-07-21
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
NCT07049926Renal Cell Carcinoma
DrugsZanzalintinib·Belzutifan
Merck Sharp & Dohme LLC
Phase 1/2
140
Seoul
2025-07-20
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168Acute Myeloid Leukemia, Leukemia
DrugQuizartinib
Daiichi Sankyo
Phase 2
130
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon
2025-07-18
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
DrugBesremi
PharmaEssentia
Phase 3
160
Daegu, Seongnam-si, Hwasun, Seocho, Seoul
2025-07-18
Recruiting
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
NCT07093476T2DM, Diabete Type 2, DM
DrugsMetformin·Dapagliflozin
Celltrion
Phase 3
171
Seoul
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Cheongju-si, Goyang-si, Incheon, Seoul
2025-07-17
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
NCT07015697Recurrent or Metastatic Solid Tumors
DrugTrastuzumab deruxtecan
Daiichi Sankyo
Phase 1
76
Seongnam-si, Seoul
2025-07-17
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745Alzheimer's Disease
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
426
Incheon, Seoul, Deagu
2025-07-16
Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494Early Alzheimer's Disease
Merck Sharp & Dohme LLC
Phase 2
340
Seoul
2025-07-16
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma
DrugsBevacizumab biosimilar·Calderasib·Adrucil·Cetuximab
Merck Sharp & Dohme LLC
Phase 3
477
Goyang-si, Seongnam-si, Suwon, Gangnam, Songpa-gu, Buk-Gu, Seoul
2025-07-16
Recruiting
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NCT07107230Advanced Stage Solid Tumors
DrugAmivantamab
Janssen Research & Development, LLC
Phase 1
400
Seoul
2025-07-15
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164Myocardial Infarction (MI), Heart Failure
Chonnam National University Hospital
Not applicable
780
Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam
2025-07-15
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827Kidney Disease
DrugMezagitamab
Takeda
Phase 3
347
Suwon, Seongnam-si, Seoul
2025-07-15
Rows per page Showing 801–900 of 3364
Previous 7 8 9 10 11 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-south-korea?page=9

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,364 studies in total at the last sync on 26 Sep 2026, 19:49 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in South Korea?

1,829 of the 3,364 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:49 UTC sync. A further 282 have not yet opened recruitment, 1,148 are active but closed to new participants, and 105 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (89) Coronary Artery Disease (79) Multiple Myeloma (45) Gastric Cancer (43) Non-Small Cell Lung Cancer (39) Non-small Cell Lung Cancer (36) Carcinoma, Non-Small-Cell Lung (36) Hepatocellular Carcinoma (36) Advanced Solid Tumor (31) Ovarian Cancer (31) Ulcerative Colitis (30) Hypertension (29) Atrial Fibrillation (27) Crohn's Disease (26) Heart Failure (25)
→

Browse trials by site location

Seoul (2820) Daegu (550) Seongnam-si (485) Busan (464) Goyang-si (395) Incheon (347) Suwon (334) Daejeon (214) Gyeonggi-do (208) Gwangju (206) Seongnam (204) Cheongju-si (185) Yangsan (120) Bucheon-si (111) Wลnju (90)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.